Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Innodata | INOD | Mar 17, 2025 | 45.93 | -4.67 |
Innospec | IOSP | Mar 17, 2025 | 99.17 | +1.10 |
InnovAge | INNV | Mar 17, 2025 | 3.28 | +1.86 |
Innovate | VATE | Mar 17, 2025 | 8.10 | +3.71 |
Innovation Beverage Group | IBG | Mar 17, 2025 | 0.47 | +0.21 |
Innovative Eyewear | LUCY | Mar 17, 2025 | 3.69 | -0.94 |
Innovative Industrial Properties | IIPR | Mar 17, 2025 | 64.21 | -7.77 |
Innovative Industrial Properties A Pref | IIPR-A | Mar 17, 2025 | 25.29 | -0.04 |
Innovative Solutions and Support | ISSC | Mar 17, 2025 | 6.89 | +3.45 |
Innovex International | INVX | Mar 17, 2025 | 18.36 | +3.49 |
Innovid | CTV | Mar 17, 2025 | 3.14 | 0.00 |
Innoviva | INVA | Mar 17, 2025 | 17.53 | +0.81 |
Innoviz Technologies | INVZ | Mar 17, 2025 | 0.67 | +3.72 |
InnSuites Hospitality | IHT | Mar 17, 2025 | 2.59 | +1.97 |
Innventure | INV | Mar 17, 2025 | 7.68 | -2.54 |
Inogen | INGN | Mar 17, 2025 | 7.50 | +0.67 |
Inotiv | NOTV | Mar 17, 2025 | 3.11 | +4.36 |
Inovio Pharmaceuticals | INO | Mar 17, 2025 | 2.11 | +3.94 |
Inozyme Pharma | INZY | Mar 17, 2025 | 1.02 | +2.00 |
InPoint Commercial Real Estate Pref A | ICR-A | Mar 17, 2025 | 19.86 | +1.99 |
Inseego | INSG | Mar 17, 2025 | 9.74 | +0.41 |
Insight Enterprises | NSIT | Mar 17, 2025 | 154.87 | +2.27 |
Insmed | INSM | Mar 17, 2025 | 77.77 | +1.59 |
Insperity | NSP | Mar 17, 2025 | 88.28 | -0.83 |
Inspira Technologies Oxy B.H.N. | IINN | Mar 17, 2025 | 0.71 | -2.70 |
Inspirato A | ISPO | Mar 17, 2025 | 3.98 | +2.05 |
Inspire Medical Systems | INSP | Mar 17, 2025 | 166.59 | +2.73 |
Inspire Tactical Balanced ESG ETF | RISN | Mar 17, 2025 | 25.87 | -0.39 |
Inspire Veterinary Partners | IVP | Mar 17, 2025 | 2.01 | +8.06 |
Inspired Entertainment | INSE | Mar 17, 2025 | 9.17 | +9.56 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.